MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 117 filers reported holding MIRUM PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,175,038 | +465.2% | 163,767 | +362.7% | 0.00% | – |
| Q2 2023 | $915,618 | -6.1% | 35,393 | -12.8% | 0.00% | – |
| Q1 2023 | $974,636 | +22.1% | 40,576 | -0.9% | 0.00% | – |
| Q4 2022 | $798,448 | +17.1% | 40,946 | +26.1% | 0.00% | – |
| Q3 2022 | $682,000 | +7.2% | 32,481 | -0.7% | 0.00% | – |
| Q2 2022 | $636,000 | -5.8% | 32,702 | +6.6% | 0.00% | – |
| Q1 2022 | $675,000 | -11.4% | 30,691 | -35.7% | 0.00% | – |
| Q4 2021 | $762,000 | -3.1% | 47,757 | +21.1% | 0.00% | – |
| Q3 2021 | $786,000 | -3.9% | 39,438 | -16.7% | 0.00% | – |
| Q2 2021 | $818,000 | -9.2% | 47,328 | +4.1% | 0.00% | – |
| Q1 2021 | $901,000 | +14.8% | 45,470 | +1.1% | 0.00% | – |
| Q4 2020 | $785,000 | +13.6% | 44,965 | +25.5% | 0.00% | – |
| Q3 2020 | $691,000 | – | 35,822 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 6,470,392 | $204,464,387 | 13.58% |
| NEA Management Company, LLC | 2,186,243 | $69,085,279 | 5.34% |
| TANG CAPITAL MANAGEMENT LLC | 1,137,107 | $35,932,581 | 5.07% |
| BOONE CAPITAL MANAGEMENT LLC | 389,791 | $12,317,396 | 3.89% |
| Highlander Partners, L.P. | 122,980 | $3,886,168 | 3.84% |
| BVF INC/IL | 4,370,024 | $138,092,758 | 3.72% |
| Prosight Management, LP | 353,508 | $11,170,853 | 3.54% |
| Novo Holdings A/S | 1,500,000 | $47,400,000 | 3.50% |
| Nicholas Investment Partners, LP | 1,199,366 | $37,899,966 | 2.83% |
| Eventide Asset Management | 3,958,579 | $125,091,097 | 2.25% |